Literature DB >> 21831764

Analysis of the intestinal microbiota of oligosaccharide fed mice exhibiting reduced resistance to Salmonella infection.

A Petersen1, A Bergström, J B Andersen, M Hansen, S J Lahtinen, A Wilcks, T R Licht.   

Abstract

Certain indigestible carbohydrates, known as prebiotics, are claimed to be beneficial for gut health through a selective stimulation of certain gut microbes including bifidobacteria. However, stimulation of such microbes does not necessarily imply a preventive effect against pathogen infection. We recently demonstrated a reduced resistance to Salmonella infection in mice fed diets containing fructo-oligosaccharides (FOS) or xylo-oligosaccharides (XOS). In the present study, faecal and caecal samples from the same mice were analysed in order to study microbial changes potentially explaining the observed effects on the pathogenesis of Salmonella. Denaturing gradient gel electrophoresis revealed that the microbiota in faecal samples from mice fed FOS or XOS were different from faecal samples collected before the feeding trial as well as from faecal profiles generated from control animals. This difference was not seen for caecal profiles. Further analysis of faecal samples by real-time PCR demonstrated a significant increase in the Bacteroidetes phylum, the Bacteroides fragilis group and in Bifidobacterium spp. in mice fed FOS or XOS. The observed bifidogenic effect was more pronounced for XOS than for FOS. The Firmicutes phylum and the Clostridium coccoides group were reduced by both FOS and XOS. Surprisingly, no significant differences were detected between faecal samples collected before and after pathogen challenge in any of the groups. Furthermore, no effect of diets on caecal concentrations of short-chain fatty acids was recorded. In conclusion, diets supplemented with FOS or XOS induced a number of microbial changes in the faecal microbiota of mice. The observed effects of XOS were qualitatively similar to those of FOS, but the most prominent bifidogenic effect was seen for XOS. An increased level of bifidobacteria is thus not in itself preventive against Salmonella infection, since the same XOS or FOS-fed mice were previously reported to be more severely affected by Salmonella than control animals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21831764     DOI: 10.3920/BM2010.0016

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  10 in total

1.  Targeting gut microbiota and barrier function with prebiotics to alleviate autoimmune manifestations in NOD mice.

Authors:  Camilla H F Hansen; Christian S Larsen; Henriette O Petersson; Line F Zachariassen; Andreas Vegge; Charlotte Lauridsen; Witold Kot; Łukasz Krych; Dennis S Nielsen; Axel K Hansen
Journal:  Diabetologia       Date:  2019-05-28       Impact factor: 10.122

2.  In vitro fermentation of sugar beet arabino-oligosaccharides by fecal microbiota obtained from patients with ulcerative colitis to selectively stimulate the growth of Bifidobacterium spp. and Lactobacillus spp.

Authors:  Louise Kristine Vigsnæs; Jesper Holck; Anne S Meyer; Tine Rask Licht
Journal:  Appl Environ Microbiol       Date:  2011-10-07       Impact factor: 4.792

Review 3.  The Role of Nutritional Factors in the Modulation of the Composition of the Gut Microbiota in People with Autoimmune Diabetes.

Authors:  Anna Winiarska-Mieczan; Ewa Tomaszewska; Janine Donaldson; Karolina Jachimowicz
Journal:  Nutrients       Date:  2022-06-16       Impact factor: 6.706

4.  The role of milk sialyllactose in intestinal bacterial colonization.

Authors:  G Adrienne Weiss; Thierry Hennet
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

5.  Dietary xylo-oligosaccharide stimulates intestinal bifidobacteria and lactobacilli but has limited effect on intestinal integrity in rats.

Authors:  Ellen Gerd Christensen; Tine Rask Licht; Thomas Dyrmann Leser; Martin Iain Bahl
Journal:  BMC Res Notes       Date:  2014-09-19

6.  Macroalga-Derived Alginate Oligosaccharide Alters Intestinal Bacteria of Atlantic Salmon.

Authors:  Shruti Gupta; Jep Lokesh; Yousri Abdelhafiz; Prabhugouda Siriyappagouder; Ronan Pierre; Mette Sørensen; Jorge M O Fernandes; Viswanath Kiron
Journal:  Front Microbiol       Date:  2019-09-13       Impact factor: 5.640

7.  Structurally Different Pectic Oligosaccharides Produced from Apple Pomace and Their Biological Activity In Vitro.

Authors:  Agnieszka Wilkowska; Adriana Nowak; Aneta Antczak-Chrobot; Ilona Motyl; Agata Czyżowska; Anna Paliwoda
Journal:  Foods       Date:  2019-08-26

8.  Dietary prebiotics promote intestinal Prevotella in association with a low-responding phenotype in a murine oxazolone-induced model of atopic dermatitis.

Authors:  Ann Laigaard; Lukasz Krych; Line F Zachariassen; Lea Ellegaard-Jensen; Dennis S Nielsen; Axel K Hansen; Camilla H F Hansen
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

9.  Microbiotas from UC patients display altered metabolism and reduced ability of LAB to colonize mucus.

Authors:  Louise Kristine Vigsnaes; Pieter van den Abbeele; Karolina Sulek; Henrik Lauritz Frandsen; Casper Steenholdt; Jørn Brynskov; Joan Vermeiren; Tom van de Wiele; Tine Rask Licht
Journal:  Sci Rep       Date:  2013-01-23       Impact factor: 4.379

10.  Xylo-oligosaccharides and inulin affect genotoxicity and bacterial populations differently in a human colonic simulator challenged with soy protein.

Authors:  Claus T Christophersen; Anne Petersen; Tine R Licht; Michael A Conlon
Journal:  Nutrients       Date:  2013-09-23       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.